Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Completed 4Unknown 2Terminated 1

Sponsor Class

NIH 4INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Other 1

Conditions

Prostatic Neoplasms 4Urinary Incontinence 1Sexual Dysfunction, Physiological 1

Interventions

Cyclophosphamide 178Radiotherapy 147Paclitaxel 128Carboplatin 124Bevacizumab 123Cisplatin 119Doxorubicin 111Fluorouracil 107Etoposide 102Filgrastim 99Vincristine 88Leucovorin 82Bortezomib 80Gemcitabine 76aldesleukin 74Sorafenib 70Cytarabine 70Taxes 69fludarabine phosphate 67Irinotecan 66Docetaxel 64Oxaliplatin 60sargramostim 58Sirolimus 58temsirolimus 56Erlotinib Hydrochloride 56Methotrexate 55Rituximab 54Vorinostat 52Radiation 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × NIH × High-Intensity Focused Ultrasound Ablation × Clear all
NCT00561262 2013-08-26

High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Completed
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT00561314 2013-08-26

High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Completed
33 enrolled
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological, Urinary Incontinence

NCT00030277 2013-07-10

High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Completed
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT00030290 2013-07-10

Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate

National Cancer Institute (NCI)

Phase 1 Completed
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡